<?xml version="1.0" encoding="UTF-8" ?><xml><records><record><database name="TestLibrary.enl" path="C:\Users\TestC\Documents\TestLibrary.enl">TestLibrary.enl</database><source-app name="EndNote" version="17.1">EndNote</source-app><rec-number>5</rec-number><foreign-keys><key app="EN" db-id="fzp5ar20q090wae90dqvzs21s2090a22vsxv">5</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Amiya, E.</style></author><author><style face="normal" font="default" size="100%">Watanabe, M.</style></author><author><style face="normal" font="default" size="100%">Komuro, I.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The Relationship between Vascular Function and the Autonomic Nervous System</style></title><secondary-title><style face="normal" font="default" size="100%">Ann Vasc Dis</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Annals of vascular diseases</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Ann Vasc Dis</style></full-title><abbr-1><style face="normal" font="default" size="100%">Annals of vascular diseases</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Ann Vasc Dis</style></full-title><abbr-1><style face="normal" font="default" size="100%">Annals of vascular diseases</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">109-19</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2014/07/06</style></edition><keywords><keyword><style face="normal" font="default" size="100%">autonomic nervous system</style></keyword><keyword><style face="normal" font="default" size="100%">endothelial cells</style></keyword><keyword><style face="normal" font="default" size="100%">endothelial function</style></keyword><keyword><style face="normal" font="default" size="100%">vascular function</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><isbn><style face="normal" font="default" size="100%">1881-641X (Print)&#xD;1881-641x</style></isbn><accession-num><style face="normal" font="default" size="100%">24995054</style></accession-num><abstract><style face="normal" font="default" size="100%">Endothelial dysfunction and autonomic nervous system dysfunction are both risk factors for atherosclerosis. There is evidence demonstrating that there is a close interrelationship between these two systems. In hypertension, endothelial dysfunction affects the pathologic process through autonomic nervous pathways, and the pathophysiological process of autonomic neuropathy in diabetes mellitus is closely related with vascular function. However, detailed mechanisms of this interrelationship have not been clearly explained. In this review, we summarize findings concerning the interrelationship between vascular function and the autonomic nervous system from both experimental and clinical studies. The clarification of this interrelationship may provide more comprehensive risk stratification and a new effective therapeutic strategy against atherosclerosis.</style></abstract><notes><style face="normal" font="default" size="100%">Amiya, Eisuke&#xD;Watanabe, Masafumi&#xD;Komuro, Issei&#xD;Journal Article&#xD;Review&#xD;Japan&#xD;Ann Vasc Dis. 2014;7(2):109-19. doi: 10.3400/avd.ra.14-00048. Epub 2014 May 16.</style></notes><urls></urls><custom2><style face="normal" font="default" size="100%">Pmc4072858</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.3400/avd.ra.14-00048</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">eng</style></language></record><record><database name="TestLibrary.enl" path="C:\Users\TestC\Documents\TestLibrary.enl">TestLibrary.enl</database><source-app name="EndNote" version="17.1">EndNote</source-app><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="fzp5ar20q090wae90dqvzs21s2090a22vsxv">1</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Annalisa, N.</style></author><author><style face="normal" font="default" size="100%">Alessio, T.</style></author><author><style face="normal" font="default" size="100%">Claudette, T. D.</style></author><author><style face="normal" font="default" size="100%">Erald, V.</style></author><author><style face="normal" font="default" size="100%">Antonino, D. L.</style></author><author><style face="normal" font="default" size="100%">Nicola, D. D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Hypertension and Nephrology, Department of System Medicine, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.&#xD;Departement of Diagnostic and Molecular Imaging, Interventional Radiology and Radiation Therapy, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.&#xD;Department of Biomedicine and Prevention, Division of Clinical Nutrition and Nutrigenomic, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Gut Microbioma Population: An Indicator Really Sensible to Any Change in Age, Diet, Metabolic Syndrome, and Life-Style</style></title><secondary-title><style face="normal" font="default" size="100%">Mediators Inflamm</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Mediators of inflammation</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Mediators Inflamm</style></full-title><abbr-1><style face="normal" font="default" size="100%">Mediators of inflammation</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Mediators Inflamm</style></full-title><abbr-1><style face="normal" font="default" size="100%">Mediators of inflammation</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">901308</style></pages><volume><style face="normal" font="default" size="100%">2014</style></volume><edition><style face="normal" font="default" size="100%">2014/07/08</style></edition><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><isbn><style face="normal" font="default" size="100%">0962-9351</style></isbn><accession-num><style face="normal" font="default" size="100%">24999296</style></accession-num><abstract><style face="normal" font="default" size="100%">Obesity has become a pandemic threat in the latest 30 years. The trend of the prevalence of overweight and obesity has got an overall increase in every part of the world, regardless of ethnicity, life-style and social ties. High food intake, genetic, and sedentary have been related to obesity; it has been also hypothesized that gut microbiota could have an impact on the complex mechanism underlying the weight gain. This review aims to illustrate the actual literature about gut microbiota and its relation with obesity and to analyze the possible implications of factors such as diet and life-style onto the composition of gut microbiota, that can lead to overweight/obesity condition.</style></abstract><notes><style face="normal" font="default" size="100%">1466-1861&#xD;Annalisa, Noce&#xD;Alessio, Tarantino&#xD;Claudette, Tsague Djoutsop&#xD;Erald, Vasili&#xD;Antonino, De Lorenzo&#xD;Nicola, Di Daniele&#xD;Review&#xD;Mediators Inflamm. 2014;2014:901308. Epub 2014 Jun 4.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1155/2014/901308</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">Eng</style></language></record><record><database name="TestLibrary.enl" path="C:\Users\TestC\Documents\TestLibrary.enl">TestLibrary.enl</database><source-app name="EndNote" version="17.1">EndNote</source-app><rec-number>3</rec-number><foreign-keys><key app="EN" db-id="fzp5ar20q090wae90dqvzs21s2090a22vsxv">3</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Chrysant, S. G.</style></author><author><style face="normal" font="default" size="100%">Chrysant, G. S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Cardiology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma; Department of Cardiology, INTEGRIS Baptist Medical Center, Oklahoma City, Oklahoma. Electronic address: schrysant@yahoo.com.&#xD;Department of Cardiology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma; Department of Cardiology, INTEGRIS Baptist Medical Center, Oklahoma City, Oklahoma.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Future of Polypill Use for the Prevention of Cardiovascular Disease and Strokes</style></title><secondary-title><style face="normal" font="default" size="100%">Am J Cardiol</style></secondary-title><alt-title><style face="normal" font="default" size="100%">The American journal of cardiology</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Am J Cardiol</style></full-title><abbr-1><style face="normal" font="default" size="100%">The American journal of cardiology</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Am J Cardiol</style></full-title><abbr-1><style face="normal" font="default" size="100%">The American journal of cardiology</style></abbr-1></alt-periodical><edition><style face="normal" font="default" size="100%">2014/07/06</style></edition><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun 6</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0002-9149</style></isbn><accession-num><style face="normal" font="default" size="100%">24996555</style></accession-num><abstract><style face="normal" font="default" size="100%">Cardiovascular disease (CVD) remains still the leading cause of death in the United States, and it is estimated to be the leading cause of death in the developing countries by 2020. In addition, the modifiable cardiovascular risk factors (CVRFs), hypertension, hypercholesterolemia, diabetes, and obesity, have increased significantly and by 2020 will account for 80% of all CVD deaths worldwide. Because the CVD and stroke risk increases significantly for subjects aged &gt;50 years, it has been proposed to treat these subjects with a polypill containing 4 to 5 drugs, which is known to reduce the CVRFs for all subjects aged &gt;/=55 years with an estimated reduction of CVD and stroke by 80%. However, this proposal is neither practical nor cost-effective, because it will involve a large number of subjects. Some investigators suggest to incorporate the coronary artery calcium score (CACS) with the Framingham Risk Score (FRS) to reduce the number of subjects who will benefit from the polypill. They have shown that patients with a CACS = 0 at age 50 years will derive no benefit from the polypill regardless of existing CVRFs, whereas those with a CACS of &gt;100 will derive the best benefit. This strategy will reduce the number of qualified subjects for treatment with the polypill by 60%. Greater benefits will be derived with the combination of CACS and FRS. Additionally, other issues will have to be considered before approval of a polypill, and these issues will be discussed in this concise review. In conclusion, a polypill treatment strategy may be effective in the prevention of CVD and stroke, but, to be cost-effective, it may be reasonable to target patients with a high CACS and FRS.</style></abstract><notes><style face="normal" font="default" size="100%">1879-1913&#xD;Chrysant, Steven G&#xD;Chrysant, George S&#xD;Review&#xD;Am J Cardiol. 2014 Jun 6. pii: S0002-9149(14)01242-9. doi: 10.1016/j.amjcard.2014.05.049.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.amjcard.2014.05.049</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">Eng</style></language></record><record><database name="TestLibrary.enl" path="C:\Users\TestC\Documents\TestLibrary.enl">TestLibrary.enl</database><source-app name="EndNote" version="17.1">EndNote</source-app><rec-number>4</rec-number><foreign-keys><key app="EN" db-id="fzp5ar20q090wae90dqvzs21s2090a22vsxv">4</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Estes, E. H.</style></author><author><style face="normal" font="default" size="100%">Kerivan, L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Duke University Medical Center, Durham, NC. Electronic address: eestes@nc.rr.com.&#xD;Duke University Medical Center, Durham, NC.</style></auth-address><titles><title><style face="normal" font="default" size="100%">An archaeologic dig: A rice-fruit diet reverses ECG changes in hypertension</style></title><secondary-title><style face="normal" font="default" size="100%">J Electrocardiol</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Journal of electrocardiology</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Electrocardiol</style></full-title><abbr-1><style face="normal" font="default" size="100%">Journal of electrocardiology</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">J Electrocardiol</style></full-title><abbr-1><style face="normal" font="default" size="100%">Journal of electrocardiology</style></abbr-1></alt-periodical><edition><style face="normal" font="default" size="100%">2014/07/06</style></edition><keywords><keyword><style face="normal" font="default" size="100%">ECG changes with hypertension</style></keyword><keyword><style face="normal" font="default" size="100%">Hypertension</style></keyword><keyword><style face="normal" font="default" size="100%">Reversal of ECG changes with hypertension</style></keyword><keyword><style face="normal" font="default" size="100%">Rice diet</style></keyword><keyword><style face="normal" font="default" size="100%">Sodium restriction</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun 4</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0022-0736</style></isbn><accession-num><style face="normal" font="default" size="100%">24996514</style></accession-num><abstract><style face="normal" font="default" size="100%">In 1940, a young German refugee physician scientist at Duke University in Durham, North Carolina began to treat patients with accelerated or &quot;malignant&quot; hypertension with a radical diet consisting of only white rice and fruit, with strikingly favorable results. He reported rapid reduction in blood pressure, rapid improvement in renal failure, papilledema, congestive heart failure and other manifestations of this previously fatal illness. This treatment was based on his theory that the kidney had both an excretory and a metabolic function, and that removing most of the sodium and protein burden from this organ enabled it to regain its normal ability to perform its more important metabolic functions. It was also effective in &quot;ordinary&quot; hypertension, in the absence of the dramatic vasculopathy of the accelerated form. The results were so dramatic that many experienced physicians suspected him of falsifying data. Among these results was the normalization of the ECG changes seen with hypertension. This paper reviews his published experience with this radical therapy, its controversial rise to fame, and its decline in popularity with the advent of effective antihypertensive drugs. It features the ECG changes seen in this then fatal disease, and the reversal of these changes by the rice diet. This treatment, though very difficult for the patient, produced effects which make it equal or superior to current multi-drug treatment of hypertension. A poorly known but important observation was that patients who were able to follow the regime, and who were slowly guided through a gradual modification of the diet over many months, were able to transition into a very tolerable low fat, largely vegetarian diet, while leading a normal, active life, without medications, indicating that the disease state had been permanently modified.</style></abstract><notes><style face="normal" font="default" size="100%">1532-8430&#xD;Estes, E Harvey&#xD;Kerivan, Lauren&#xD;Review&#xD;J Electrocardiol. 2014 Jun 4. pii: S0022-0736(14)00165-4. doi: 10.1016/j.jelectrocard.2014.05.008.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.jelectrocard.2014.05.008</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">Eng</style></language></record><record><database name="TestLibrary.enl" path="C:\Users\TestC\Documents\TestLibrary.enl">TestLibrary.enl</database><source-app name="EndNote" version="17.1">EndNote</source-app><rec-number>2</rec-number><foreign-keys><key app="EN" db-id="fzp5ar20q090wae90dqvzs21s2090a22vsxv">2</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">King, C.</style></author><author><style face="normal" font="default" size="100%">May, C. W.</style></author><author><style face="normal" font="default" size="100%">Williams, J.</style></author><author><style face="normal" font="default" size="100%">Shlobin, O. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Medical Critical Care Service, Inova Fairfax Hospital, 618 South Royal Street, Alexandria, VA 22314, USA. Electronic address: Csking123@hotmail.com.&#xD;Advanced Heart Failure and Cardiac Transplant Program, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA.&#xD;Medical Critical Care Service, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA.&#xD;Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Management of Right Heart Failure in the Critically Ill</style></title><secondary-title><style face="normal" font="default" size="100%">Crit Care Clin</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Critical care clinics</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Crit Care Clin</style></full-title><abbr-1><style face="normal" font="default" size="100%">Critical care clinics</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Crit Care Clin</style></full-title><abbr-1><style face="normal" font="default" size="100%">Critical care clinics</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">475-498</style></pages><volume><style face="normal" font="default" size="100%">30</style></volume><number><style face="normal" font="default" size="100%">3</style></number><edition><style face="normal" font="default" size="100%">2014/07/06</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Acute respiratory distress syndrome</style></keyword><keyword><style face="normal" font="default" size="100%">Pulmonary hypertension</style></keyword><keyword><style face="normal" font="default" size="100%">Right ventricular dysfunction</style></keyword><keyword><style face="normal" font="default" size="100%">Right ventricular failure</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0749-0704</style></isbn><accession-num><style face="normal" font="default" size="100%">24996606</style></accession-num><abstract><style face="normal" font="default" size="100%">Right ventricular failure complicates several commonly encountered conditions in the intensive care unit. Right ventricular dilation and paradoxic movement of the interventricular septum on echocardiography establishes the diagnosis. Right heart catheterization is useful in establishing the specific cause and aids clinicians in management. Principles of treatment focus on reversal of the underlying cause, optimization of right ventricular preload and contractility, and reduction of right ventricular afterload. Mechanical support with right ventricular assist device or veno-arterial extracorporeal membrane oxygenation can be used in select patients who fail to improve with optimal medical therapy.</style></abstract><notes><style face="normal" font="default" size="100%">1557-8232&#xD;King, Christopher&#xD;May, Christopher W&#xD;Williams, Jeffrey&#xD;Shlobin, Oksana A&#xD;Review&#xD;Crit Care Clin. 2014 Jul;30(3):475-498. doi: 10.1016/j.ccc.2014.03.003.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.ccc.2014.03.003</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">Eng</style></language></record><record><database name="TestLibrary.enl" path="C:\Users\TestC\Documents\TestLibrary.enl">TestLibrary.enl</database><source-app name="EndNote" version="17.1">EndNote</source-app><rec-number>10</rec-number><foreign-keys><key app="EN" db-id="fzp5ar20q090wae90dqvzs21s2090a22vsxv">10</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Martinez-Varea, A.</style></author><author><style face="normal" font="default" size="100%">Pellicer, B.</style></author><author><style face="normal" font="default" size="100%">Perales-Marin, A.</style></author><author><style face="normal" font="default" size="100%">Pellicer, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Obstetrics and Gynecology, Hospital Universitario y Politecnico La Fe, Avenida Bulevar Sur s/n, Valencia 46026, Spain.&#xD;Department of Obstetrics and Gynecology, Hospital General Universitario, Avenida Tres Cruces 2, Valencia 46014, Spain.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Relationship between Maternal Immunological Response during Pregnancy and Onset of Preeclampsia</style></title><secondary-title><style face="normal" font="default" size="100%">J Immunol Res</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Journal of immunology research</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Immunol Res</style></full-title><abbr-1><style face="normal" font="default" size="100%">Journal of immunolog